We have worked with Cyclacel, a biopharmaceutical company specialising in the development of drugs for the treatment of cancer. We prepared an R&D repayment claim and an RDEC (Research & Development Expenditure Credit, also known as ‘above the line’) tax claim, resulting in a significant cash repayment for the client which was paid four weeks after the accounts were signed.
We also conducted a Patent Box feasibility study to establish if the company was eligible for the new tax relief. This was an interesting project which addressed a number of key technical issues.
We were delighted to work with Cyclacel, a key innovative company in the Scottish Bioscience sector. The work was carried out, on time, on budget and the client was happy with the outcome. We will continue to work with the client as they take their development to the next stage.